Coxiella Burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages
Overview
Authors
Affiliations
is an obligate intracellular bacterium and the etiological agent of Q fever. Successful host cell infection requires the type IVB secretion system (T4BSS), which translocates bacterial effector proteins across the vacuole membrane into the host cytoplasm, where they manipulate a variety of cell processes. To identify host cell targets of T4BSS effector proteins, we determined the transcriptome of murine alveolar macrophages infected with a T4BSS effector mutant. We identified a set of inflammatory genes that are significantly upregulated in T4BSS mutant-infected cells compared to mock-infected cells or cells infected with wild-type (WT) bacteria, suggesting that T4BSS effector proteins downregulate the expression of these genes. In addition, the interleukin-17 (IL-17) signaling pathway was identified as one of the top pathways affected by the bacteria. While previous studies demonstrated that IL-17 plays a protective role against several pathogens, the role of IL-17 during infection is unknown. We found that IL-17 kills intracellular in a dose-dependent manner, with the T4BSS mutant exhibiting significantly more sensitivity to IL-17 than WT bacteria. In addition, quantitative PCR confirmed the increased expression of IL-17 downstream signaling genes in T4BSS mutant-infected cells compared to WT- or mock-infected cells, including the proinflammatory cytokine genes , , and , the chemokine genes and , and the antimicrobial protein gene We further confirmed that the T4BSS downregulates macrophage CXCL2/macrophage inflammatory protein 2 and CCL5/RANTES protein levels following IL-17 stimulation. Together, these data suggest that downregulates IL-17 signaling in a T4BSS-dependent manner in order to escape the macrophage immune response.
CYP1B1-AS1 regulates CYP1B1 to promote pathogenesis by inhibiting ROS and host cell death.
Arunima A, Niyakan S, Butler S, Clark S, Pinson A, Kwak D Res Sq. 2024; .
PMID: 39711545 PMC: 11661375. DOI: 10.21203/rs.3.rs-5390645/v1.
Osbron C, Lawson C, Hanna N, Koehler H, Goodman A Infect Immun. 2024; 92(7):e0005324.
PMID: 38837340 PMC: 11238558. DOI: 10.1128/iai.00053-24.
Osbron C, Lawson C, Hanna N, Koehler H, Goodman A bioRxiv. 2024; .
PMID: 38352389 PMC: 10862817. DOI: 10.1101/2024.02.02.578698.
Recent advances in genetic systems in obligate intracellular human-pathogenic bacteria.
Fisher D, Beare P Front Cell Infect Microbiol. 2023; 13:1202245.
PMID: 37404720 PMC: 10315504. DOI: 10.3389/fcimb.2023.1202245.
Schuler B, Sladek M, Gilk S mSphere. 2023; 8(3):e0010423.
PMID: 37017523 PMC: 10286706. DOI: 10.1128/msphere.00104-23.